Recently, some researchers proposed that combination of KRAS mutation-based cancer vaccines and other immune therapy methods may evade immunosuppression and enhance the chance of a successful tumor treatment (Zhang Y. et al., 2020). The gene discussed is KRAS; the disease is neoplasm.